The Big3Bio Event Preview – EPPICon 2016

It all begins with accurate diagnostics. Discovery of accurate biomarkers triggers the development of new therapeutic drugs as well as companion patient side diagnostic tools, and advances and miniaturization in digital health technology are now leading the democratization of diagnostics by placing these critical tools in the form of wearables and cloud-connected home devices in […]

Read More

More Problems at Theranos

Excerpts from various media coverage regarding US regulators saying that a Theranos lab poses an “immediate jeopardy” to patient safety — and a statement from Theranos: Forbes: Some Theranos Tests ‘Pose Immediate Jeopardy To Patient Health And Safety’ “A letter sent to Theranos by U.S. regulators says problems with the company’s blood tests “pose immediate jeopardy […]

Read More

Event Recap: ARM’s Regenerative Medicine State of the Industry

By Dr. Karen Ring for Big3Bio Every January, downtown San Francisco is taken over by a flock of investors, bankers, biotech companies, and scientists attending the annual JP Morgan Healthcare Conference. This meeting looks at the healthcare advancements over the past year and predicts the disease areas and technologies that will see the most progress […]

Read More

Working the JP Morgan Healthcare Conference 2016: More, More, More – How Do You Like It?

It’s coming around to that big week in San Francisco again. Many love it, many eyeroll it – but the second week of January is crucial for the healthcare investing world, with the JP Morgan Healthcare Conference (#JPM16) being the main event that will draw thousands. Of course, this means the many receptions, receptions, receptions, but also this year, there are even more events […]

Read More

Event Recap: primeUC Crowns its First Startup Champions

By Dr. Karen Ring for Big3Bio California is a hotbed for promising startups in technology, healthcare and the life sciences. Many of the innovative ideas that spawn these companies originate from labs and universities. One of the leaders in scientific entrepreneurship is the University of California (UC). Among its 10 campuses, five medical centers and […]

Read More

Event Recap: Celebrating Life Science Leaders at CLSA Pantheon Awards

By Dr. Karen Ring for Big3Bio The science world might not seem as glamorous as Hollywood and the red carpet, but last night the California Life Sciences Association (CLSA) threw an awards ceremony worthy of the Oscars. With a program that included everything from beakers to bagpipe players, the 2015 CLSA Pantheon DiNA Awards honored […]

Read More

Part 2 of Q&A with CLSA CEO Sara Radcliffe

Note: Ahead of the BIO Investor Forum in San Francisco, Big3Bio is combining its Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe (part 1 here) with mendelspod. This video feature will run with chapter updates every day of this week. Chapter 1: CLSA – California’s first statewide trade group for biotech   Chapter […]

Read More

Big3Bio Q&A: CLSA CEO Sara Radcliffe (Part 1)

Note: Ahead of the AdvaMed conference next week in San Diego and the BIO Investor Forum in San Francisco two weeks later, Big3Bio has a two-part Q&A series with new California Life Sciences Association (CLSA) President and CEO Sara Radcliffe – the first part is today through Friday (two questions a day), a week prior to AdvaMed, and the second part […]

Read More

Event Recap: How J&J Promotes Innovation

By Dr. Karen Ring, Big3Bio Events Correspondent How exactly does one of the largest pharmaceutical companies in the world promote scientific innovation through proactive collaboration and investment? This month’s BioScience Forum addressed that question by detailing the structure and focus of Johnson & Johnson (J&J) in an event featuring Senior Director for New Ventures, J&J Innovation, Thorsten Melcher. […]

Read More

Event Recap: Insights on the CRISPR/Cas9 Genome Editing Revolution

By Dr. Karen Ring, Big3Bio Events Correspondent It’s a pretty exciting time in the world of science. Stem cell therapies are entering human trials, CAR-T cells are bringing new hope to immuno-oncology, and advancements in genome editing technologies have put gene therapy back on the table. From a therapeutic perspective, the CRISPR/Cas9 genome editing system is […]

Read More

International Event Recap: BIO 2015 in Philadelphia

By Dr Kristophe Diaz, Big3Bio East Coast Consultant This year’s BIO Convention was held in Philadelphia at the Pennsylvania Convention Center, and the 150,000 square feet of convention space gave 1,800 exhibitors a chance to showcase their technologies, capabilities, and, for many countries and 47 states and regions, an opportunity to share a snapshot of […]

Read More